Literature DB >> 30720492

Extracorporeal Membrane Oxygenation for Massive Pulmonary Embolism as Bridge to Therapy.

Lukasz Kmiec1, Alois Philipp1, Bernhard Floerchinger1, Matthias Lubnow2, Christoph Unterbuchner3, Markus Creutzenberg3, Dirk Lunz3, Thomas Mueller2, Christof Schmid1, Daniele Camboni1.   

Abstract

Pulmonary Embolism (PE) is a common illness in western countries. The purpose of this study is to report the institutional experience with massive PE and Extracorporeal Membrane Oxygenation (ECMO) in inoperable patients on admission. A retrospective analysis using the institutional ECMO-registry including the time between 2006 and 2017 was performed. During the study period, 75 patients (n = 46 patients venoarterial [VA], n = 29 patients venovenous [VV]) were placed on ECMO for massive PE. The primary support for massive PE consists of VA; however, VV support can be applied as well in selected cases as this work demonstrates. In the VA group, more patients (38 vs. 83%, P = 0.001) required mechanical resuscitation whereas in the VV group a more aggressive ventilation before support was noted (e.g. minute ventilation: VA=8.8 ± 3.7 L/min, VV=11.5 ± 4.5 L/min, P = 0.01). Survival to discharge was similar in VV and VA patients (45 vs. 48%, P = 0.9). Patients who received additional therapeutic interventions after stabilization with ECMO - e.g. surgical thrombectomy - displayed a similar survival compared with those being only anticoagulated (44% vs. 49%, P = 0.40). ECMO is feasible for initial stabilization serving as a bridge to therapy in primarily inoperable patients with massive PE. The principal configuration of support is VA; however, VV can be applied as well in selected hemodynamically compromised cases under aggressive ventilation.

Entities:  

Mesh:

Year:  2020        PMID: 30720492     DOI: 10.1097/MAT.0000000000000953

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  7 in total

1.  Extracorporeal Membrane Oxygenation-First Strategy for Acute Life-Threatening Pulmonary Embolism.

Authors:  Zhenjie Liu; Jinyi Chen; Xin Xu; Fen Lan; Minzhi He; Changming Shao; Yongshan Xu; Pan Han; Yibing Chen; Yongbin Zhu; Man Huang
Journal:  Front Cardiovasc Med       Date:  2022-06-03

2.  Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study.

Authors:  Christoph Fisser; Maren Winkler; Maximilian V Malfertheiner; Alois Philipp; Maik Foltan; Dirk Lunz; Florian Zeman; Lars S Maier; Matthias Lubnow; Thomas Müller
Journal:  Crit Care       Date:  2021-04-29       Impact factor: 9.097

3.  Efficacy and Safety of Veno-Arterial Extracorporeal Membrane Oxygenation in the Treatment of High-Risk Pulmonary Embolism: A Retrospective Cohort Study.

Authors:  Hao-Yu Tsai; Yu-Tang Wang; Wei-Chieh Lee; Hsu-Ting Yen; Chien-Ming Lo; Chia-Chen Wu; Kwan-Ru Huang; Yin-Chia Chen; Jiunn-Jye Sheu; Yen-Yu Chen
Journal:  Front Cardiovasc Med       Date:  2022-03-02

Review 4.  Extracorporeal Life Support in Respiratory Failure.

Authors:  Briana Short; Kristin M Burkart
Journal:  Clin Chest Med       Date:  2022-09       Impact factor: 4.967

Review 5.  Overview of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support for the Management of Cardiogenic Shock.

Authors:  Adamantios Tsangaris; Tamas Alexy; Rajat Kalra; Marinos Kosmopoulos; Andrea Elliott; Jason A Bartos; Demetris Yannopoulos
Journal:  Front Cardiovasc Med       Date:  2021-07-07

6.  Role of Pulmonary Embolism Response Team in patients with intermediate- and high-risk pulmonary embolism: a concise review and preliminary experience from China.

Authors:  Ying Liang; Shao-Ping Nie; Xiao Wang; Ashley Thomas; Elizabeth Thompson; Guan-Qi Zhao; Jing Han; Jing Wang; Mark J D Griffiths
Journal:  J Geriatr Cardiol       Date:  2020-08       Impact factor: 3.327

7.  Long-term follow-up and quality of life in patients receiving extracorporeal membrane oxygenation for pulmonary embolism and cardiogenic shock.

Authors:  Tobias J Lange; Daniele Camboni; Andrea Stadlbauer; Alois Philipp; Sebastian Blecha; Matthias Lubnow; Dirk Lunz; Jing Li; Armando Terrazas; Christof Schmid
Journal:  Ann Intensive Care       Date:  2021-12-24       Impact factor: 6.925

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.